Skip to Content
Merck
  • Protocol for Large-Scale Production of Kidney Organoids from Human Pluripotent Stem Cells.

Protocol for Large-Scale Production of Kidney Organoids from Human Pluripotent Stem Cells.

STAR protocols (2020-12-31)
Veronika Sander, Aneta Przepiorski, Amanda E Crunk, Neil A Hukriede, Teresa M Holm, Alan J Davidson
ABSTRACT

Kidney organoids represent a physiologically advanced model for studying the mechanisms of kidney development and disease. Here, we describe a simple two-step protocol for the differentiation of human pluripotent stem cells into kidney organoids. Our approach involves suspension culture that allows for rapid and cost-effective bulk production of organoids, which is well suited for large-scale assays such as drug screening. The organoids correspond to fetal human kidney tissue and may be of limited use for modeling adult kidney function. For complete details on the use and execution of this protocol, please refer to Przepiorski et al. (2018).

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Sodium chloride, BioUltra, for molecular biology, ≥99.5% (AT)
Sigma-Aldrich
Poly(vinyl alcohol), 87-90% hydrolyzed, average mol wt 30,000-70,000
Sigma-Aldrich
Horse Serum, Donor herd, USA origin, sterile-filtered, suitable for cell culture, suitable for hybridoma
Sigma-Aldrich
Sodium citrate dihydrate, ≥99%, FG
Sigma-Aldrich
Xylenes, histological grade